Report - Q3 2020 Results - GSK · 2020. 11. 4. · Continuing +3% CER Total -6% CER 613 662 541 22.3% Q319 Q320 Reported 24.3% Q319 Pro-forma 24.2%-90bps CER Operating margin Oral health Pain

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form